Akamai Technologies Inc. Stock Sheds 3.7%, Underperforms Peers
Dow Jones2026/10/07 20:35This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Akamai Technologies Inc. shed 3.7% to $104.61 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.2% to 7,801.77 and Dow Jones Industrial Average falling 0.7% to 51,179.87. Akamai Technologies Inc. closed 36.8% short of its 52-week high of $165.45, which the company achieved on May 13th. The stock underperformed when compared to some of its peers, as Synopsys Inc. fell 0.5% to $502.67, Cognizant Technology Solutions Corp. fell 0.3% to $57.07, and Arista Networks Inc. rose 0.22% to $215.83. Trading volume totaled 3.9 million, compared to the 50-day average of 4.4 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 07, 2026 16:35 ET (20:35 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Akamai Technologies Inc. shed 3.7% to $104.61 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.2% to 7,801.77 and Dow Jones Industrial Average falling 0.7% to 51,179.87.
Akamai Technologies Inc. closed 36.8% short of its 52-week high of $165.45, which the company achieved on May 13th.
The stock underperformed when compared to some of its peers, as Synopsys Inc. fell 0.5% to $502.67, Cognizant Technology Solutions Corp. fell 0.3% to $57.07, and Arista Networks Inc. rose 0.22% to $215.83.
Trading volume totaled 3.9 million, compared to the 50-day average of 4.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 07, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Amgen (AMGN.US) Q3 revenue and profit exceed expectations, company raises full-year guidance
Amgen (AMGN.US) released its Q3 2026 financial report.
Caesarstone Publishes Update to Financial Calendar
BUZZ - Amgen raises its 2026 profit and revenue forecasts; stock price drops